Literature DB >> 23563264

Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis.

Fabien Maldonado1, Teng Moua, Srinivasan Rajagopalan, Ronald A Karwoski, Sushravya Raghunath, Paul A Decker, Thomas E Hartman, Brian J Bartholmai, Richard A Robb, Jay H Ryu.   

Abstract

Accurate assessment of prognosis in idiopathic pulmonary fibrosis remains elusive due to significant individual radiological and physiological variability. We hypothesised that short-term radiological changes may be predictive of survival. We explored the use of CALIPER (Computer-Aided Lung Informatics for Pathology Evaluation and Rating), a novel software tool developed by the Biomedical Imaging Resource Laboratory at the Mayo Clinic Rochester (Rochester, MN, USA) for the analysis and quantification of parenchymal lung abnormalities on high-resolution computed tomography. We assessed baseline and follow-up (time-points 1 and 2, respectively) high-resolution computed tomography scans in 55 selected idiopathic pulmonary fibrosis patients and correlated CALIPER-quantified measurements with expert radiologists' assessments and clinical outcomes. Findings of interval change (mean 289 days) in volume of reticular densities (hazard ratio 1.91, p=0.006), total volume of interstitial abnormalities (hazard ratio 1.70, p=0.003) and per cent total interstitial abnormalities (hazard ratio 1.52, p=0.017) as quantified by CALIPER were predictive of survival after a median follow-up of 2.4 years. Radiologist interpretation of short-term global interstitial lung disease progression, but not specific radiological features, was also predictive of mortality. These data demonstrate the feasibility of quantifying interval short-term changes on high-resolution computed tomography and their possible use as independent predictors of survival in idiopathic pulmonary fibrosis.

Entities:  

Mesh:

Year:  2013        PMID: 23563264     DOI: 10.1183/09031936.00071812

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  64 in total

Review 1.  Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  Ivan O Rosas; Paul F Dellaripa; David J Lederer; Dinesh Khanna; Lisa R Young; Fernando J Martinez
Journal:  Ann Am Thorac Soc       Date:  2014-04

2.  Toward Early Identification of Clinically Relevant Interstitial Lung Disease.

Authors:  Margaret L Salisbury; David A Lynch
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

3.  Appreciating the shades of gray: a case for Computer-Aided Nodule Assessment and Risk Yield (CANARY)-based risk stratification of lung adenocarcinomas.

Authors:  Fabien Maldonado; Tobias Peikert; Brian J Bartholmai; Srinivasan Rajagopalan; Ronald A Karwoski
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

4.  Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.

Authors:  Samuel Y Ash; Rola Harmouche; Rachel K Putman; James C Ross; Alejandro A Diaz; Gary M Hunninghake; Jorge Onieva Onieva; Fernando J Martinez; Augustine M Choi; David A Lynch; Hiroto Hatabu; Ivan O Rosas; Raul San Jose Estepar; George R Washko
Journal:  Chest       Date:  2017-05-12       Impact factor: 9.410

5.  Outcome Measures for Clinical Trials in Interstitial Lung Diseases.

Authors:  Matthew R Lammi; Robert P Baughman; Surinder S Birring; Anne-Marie Russell; Jay H Ryu; Marybeth Scholand; Oliver Distler; Daphne LeSage; Catherine Sarver; Katerina Antoniou; Kristin B Highland; Otylia Kowal-Bielecka; Joseph A Lasky; Athol U Wells; Lesley Ann Saketkoo
Journal:  Curr Respir Med Rev       Date:  2015

Review 6.  Advances in Imaging and Automated Quantification of Pulmonary Diseases in Non-neoplastic Diseases.

Authors:  Fernanda Balbinot; Álvaro da Costa Batista Guedes; Douglas Zaione Nascimento; Juliana Fischman Zampieri; Giordano Rafael Tronco Alves; Edson Marchiori; Adalberto Sperb Rubin; Bruno Hochhegger
Journal:  Lung       Date:  2016-09-23       Impact factor: 2.584

7.  High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study.

Authors:  Anna J Podolanczuk; Elizabeth C Oelsner; R Graham Barr; Eric A Hoffman; Hilary F Armstrong; John H M Austin; Robert C Basner; Matthew N Bartels; Jason D Christie; Paul L Enright; Bernadette R Gochuico; Karen Hinckley Stukovsky; Joel D Kaufman; P Hrudaya Nath; John D Newell; Scott M Palmer; Dan Rabinowitz; Ganesh Raghu; Jessica L Sell; Jered Sieren; Sushil K Sonavane; Russell P Tracy; Jubal R Watts; Kayleen Williams; Steven M Kawut; David J Lederer
Journal:  Eur Respir J       Date:  2016-07-28       Impact factor: 16.671

8.  Quantitative CT characterization of pediatric lung development using routine clinical imaging.

Authors:  Jill M Stein; Laura L Walkup; Alan S Brody; Robert J Fleck; Jason C Woods
Journal:  Pediatr Radiol       Date:  2016-08-30

9.  Using hyperpolarized 129Xe MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis.

Authors:  Jennifer M Wang; Scott H Robertson; Ziyi Wang; Mu He; Rohan S Virgincar; Geoffry M Schrank; Rose Marie Smigla; Thomas G O'Riordan; John Sundy; Lukas Ebner; Craig R Rackley; Page McAdams; Bastiaan Driehuys
Journal:  Thorax       Date:  2017-08-31       Impact factor: 9.139

10.  Perfusion- and pattern-based quantitative CT indexes using contrast-enhanced dual-energy computed tomography in diffuse interstitial lung disease: relationships with physiologic impairment and prediction of prognosis.

Authors:  Jung Won Moon; Jang Pyo Bae; Ho Yun Lee; Namkug Kim; Man Pyo Chung; Hye Yun Park; Yongjun Chang; Joon Beom Seo; Kyung Soo Lee
Journal:  Eur Radiol       Date:  2015-08-09       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.